These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 26745050)
21. Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells. Kilker RL; Planas-Silva MD Cancer Res; 2006 Dec; 66(23):11478-84. PubMed ID: 17145896 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. Guthrie N; Gapor A; Chambers AF; Carroll KK J Nutr; 1997 Mar; 127(3):544S-548S. PubMed ID: 9082043 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
24. Phaleria macrocarpa (Boerl.) fruit induce G Kavitha N; Ein Oon C; Chen Y; Kanwar JR; Sasidharan S J Ethnopharmacol; 2017 Apr; 201():42-55. PubMed ID: 28263848 [TBL] [Abstract][Full Text] [Related]
25. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Reddel RR; Murphy LC; Hall RE; Sutherland RL Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620 [TBL] [Abstract][Full Text] [Related]
26. Major triterpenoids in Chinese hawthorn "Crataegus pinnatifida" and their effects on cell proliferation and apoptosis induction in MDA-MB-231 cancer cells. Wen L; Guo R; You L; Abbasi AM; Li T; Fu X; Liu RH Food Chem Toxicol; 2017 Feb; 100():149-160. PubMed ID: 28025124 [TBL] [Abstract][Full Text] [Related]
27. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J; Slivova V; Sliva D Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287 [TBL] [Abstract][Full Text] [Related]
28. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Moriya T Breast Cancer; 2016 May; 23(3):425-36. PubMed ID: 25552385 [TBL] [Abstract][Full Text] [Related]
29. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Choi YH; Yoo YH Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313 [TBL] [Abstract][Full Text] [Related]
30. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer. Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581 [TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645 [TBL] [Abstract][Full Text] [Related]
32. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Kim JB; Lee KM; Ko E; Han W; Lee JE; Shin I; Bae JY; Kim S; Noh DY Planta Med; 2008 Jan; 74(1):39-42. PubMed ID: 18203057 [TBL] [Abstract][Full Text] [Related]
33. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells. Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855 [TBL] [Abstract][Full Text] [Related]
34. The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways. Wong FC; Woo CC; Hsu A; Tan BK PLoS One; 2013; 8(10):e78021. PubMed ID: 24205071 [TBL] [Abstract][Full Text] [Related]
35. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775 [TBL] [Abstract][Full Text] [Related]
36. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Wilcken NR; Prall OW; Musgrove EA; Sutherland RL Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758 [TBL] [Abstract][Full Text] [Related]
37. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
38. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
39. Antiglycolytic Activities of Muhammad SNH; Yaacob NS; Safuwan NAM; Fauzi AN Anticancer Agents Med Chem; 2022; 22(7):1363-1369. PubMed ID: 33906591 [TBL] [Abstract][Full Text] [Related]
40. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]